Effect of Newer Long-Acting Insulins on Hypoglycemia and Fracture Risk Among People with Diabetes: A Systematic Review

被引:0
作者
Hangaard, Stine [1 ,2 ]
Jensen, Morten Hasselstrom [1 ,2 ]
机构
[1] Aalborg Univ Hosp, Steno Diabet Ctr North Denmark, Hobrovej 19, DK-9100 Aalborg, Denmark
[2] Aalborg Univ, Dept Hlth Sci & Technol, Fredrik Bajers Vej 7, DK-9210 Aalborg, Denmark
关键词
Hypoglycemia; Fractures; Insulin; Falls; Systematic review; GLUCOSE CONTROL; BASAL INSULIN; GLARGINE; TYPE-1; DEGLUDEC; THERAPY; DETEMIR; IMPACT; NPH;
D O I
10.1007/s11914-021-00706-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review To investigate the effect of newer long-acting insulins on the risk of hypoglycemic episodes and fractures in people with diabetes. Recent Findings Hypoglycemic episodes are the critical limiting factor in glycemic management due to a deteriorating effect on quality of life. Hypoglycemia may in severe cases lead to unconsciousness and thus fractures. Newer long-acting insulins may result in more stable blood glucose levels, less hypoglycemic episodes, and reduced risk of fractures. Use of insulin increases risk of hypoglycemic episodes, and hypoglycemic episodes increase risk of fractures plausible due to falls. Newer ultra-long-acting insulins reduce risk of hypoglycemic episodes compared to older alternatives, and they are thus promising for reducing fracture risk. However, more studies are needed to determine whether these new insulins reduce risk of fractures.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 36 条
  • [1] [Anonymous], 2019, Diabetes Res. Clin. Pract, DOI [DOI 10.1016/J.DIABRES.2019.107843, 10.1016/j.diabres.2019, DOI 10.1016/J.DIABRES.2019]
  • [2] Hypoglycemia unawareness
    Bakatselos, Spyridon O.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 : S92 - S96
  • [3] Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population
    Berra, Cesare
    De Fazio, Francesco
    Azzolini, Elena
    Albini, Marco
    Zangrandi, Federico
    Mirani, Marco
    Garbossa, Stefania
    Guardado-Mendoza, Rodolfo
    Condorelli, Gianluigi
    Folli, Franco
    [J]. ACTA DIABETOLOGICA, 2019, 56 (08) : 931 - 938
  • [4] Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
    Buse, John B.
    Rodbard, Helena W.
    Serrano, Carlos Trescoli
    Luo, Junxiang
    Ivanyi, Tibor
    Bue-Valleskey, Juliana
    Hartman, Mark L.
    Carey, Michelle A.
    Chang, Annette M.
    [J]. DIABETES CARE, 2016, 39 (01) : 92 - 100
  • [5] Glycemic Targets: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S61 - S70
  • [6] Childs BP, 2005, DIABETES CARE, V28, P1245
  • [7] Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk?
    Corrao, Giovanni
    Compagnoni, Matteo Monzio
    Ronco, Raffaella
    Merlino, Luca
    Ciardullo, Stefano
    Perseghin, Gianluca
    Banfi, Giuseppe
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2020, 478 (05) : 992 - 1003
  • [8] Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852
  • [9] Global trends in diabetes complications: a review of current evidence
    Harding, Jessica L.
    Pavkov, Meda E.
    Magliano, Dianna J.
    Shaw, Jonathan E.
    Gregg, Edward W.
    [J]. DIABETOLOGIA, 2019, 62 (01) : 3 - 16
  • [10] Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2
    Heller, Simon R.
    DeVries, J. Hans
    Wysham, Carol
    Hansen, Charlotte T.
    Hansen, Melissa V.
    Frier, Brian M.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (07) : 1634 - 1641